These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9603949

  • 1. Coagulation factor XIIIa undergoes a conformational change evoked by glutamine substrate. Studies on kinetics of inhibition and binding of XIIIA by a cross-reacting antifibrinogen antibody.
    Mitkevich OV, Shainoff JR, DiBello PM, Yee VC, Teller DC, Smejkal GB, Bishop PD, Kolotushkina IS, Fickenscher K, Samokhin GP.
    J Biol Chem; 1998 Jun 05; 273(23):14387-91. PubMed ID: 9603949
    [Abstract] [Full Text] [Related]

  • 2. Contact with the N termini in the central E domain enhances the reactivities of the distal D domains of fibrin to factor XIIIa.
    Samokhin GP, Lorand L.
    J Biol Chem; 1995 Sep 15; 270(37):21827-32. PubMed ID: 7665605
    [Abstract] [Full Text] [Related]

  • 3. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE, Dobson JV, Greenberg CS.
    Biochim Biophys Acta; 1986 Aug 15; 872(3):261-8. PubMed ID: 2873839
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Factor XIIIa-derived peptides inhibit transglutaminase activity. Localization of substrate recognition sites.
    Achyuthan KE, Slaughter TF, Santiago MA, Enghild JJ, Greenberg CS.
    J Biol Chem; 1993 Oct 05; 268(28):21284-92. PubMed ID: 8104938
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Monoclonal antibody directed to a fibrinogen A alpha #529-539 epitope inhibits alpha-chain crosslinking by transglutaminases.
    Mitkevich OV, Sobel JH, Shainoff JR, Vlasik TN, Kalantarov GF, Trakht IN, Streltsova ZA, Samokhin GP.
    Blood Coagul Fibrinolysis; 1996 Jan 05; 7(1):85-92. PubMed ID: 8845468
    [Abstract] [Full Text] [Related]

  • 10. Structural features of glutamine substrates for human plasma factor XIIIa (activated blood coagulation factor XIII).
    Gorman JJ, Folk JE.
    J Biol Chem; 1980 Jan 25; 255(2):419-27. PubMed ID: 6101325
    [Abstract] [Full Text] [Related]

  • 11. Biotinylated peptides containing a factor XIIIa or a tissue transglutaminase-reactive glutaminyl residue that block protein cross-linking phenomena by becoming incorporated into amine donor sites.
    Lorand L, Parameswaran KN, Velasco PT, Murthy SN.
    Bioconjug Chem; 1992 Jan 25; 3(1):37-41. PubMed ID: 1352131
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Factor XIIIa-catalyzed cross-linking of recombinant alpha C fragments of human fibrinogen.
    Matsuka YV, Medved LV, Migliorini MM, Ingham KC.
    Biochemistry; 1996 May 07; 35(18):5810-6. PubMed ID: 8639541
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tridegin, a new peptidic inhibitor of factor XIIIa, from the blood-sucking leech Haementeria ghilianii.
    Finney S, Seale L, Sawyer RT, Wallis RB.
    Biochem J; 1997 Jun 15; 324 ( Pt 3)(Pt 3):797-805. PubMed ID: 9210403
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.